Kong, L., Alffenaar, J. C., & Stocker, S. L. (2024). Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”. Clinical pharmacokinetics, 63(5), 731-733. https://doi.org/10.1007/s40262-024-01357-4
Citace podle Chicago (17th ed.)Kong, Leping, Jan-Willem C. Alffenaar, a Sophie L. Stocker. "Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”." Clinical Pharmacokinetics 63, no. 5 (2024): 731-733. https://doi.org/10.1007/s40262-024-01357-4.
Citace podle MLA (9th ed.)Kong, Leping, et al. "Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”." Clinical Pharmacokinetics, vol. 63, no. 5, 2024, pp. 731-733, https://doi.org/10.1007/s40262-024-01357-4.